Naos fund reaps life science and biotech rewards

Wed Apr 18, 2012

Read more:

Investments in Australian biotech and life sciences companies helped lift the Naos Emerging Long Short Equity Fund in March. The fund, which focuses exclusively on Australian equities, rose 9.33% in March, after a 11.83% gain in February.

"We don’t...

ISSN: 2151-1845 / CDC10004H


The full contents of this article are available to active AsiaHedge subscribers and trialists only.

To continue reading please,
take a free trial or subscribe to AsiaHedge.


Subscribers have unlimited access to all current content, including hedge fund performance Live League Tables. Start your subscription today - click on the button below.

Subscribe now

Popular Searches on HFI